Skip to main content
Contact Us
Subscribe
E-Edition
74°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Personalis, Inc. - Common Stock
(NQ:
PSNL
)
3.590
-0.230 (-6.02%)
Streaming Delayed Price
Updated: 3:34 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Personalis, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip
March 08, 2025
Ark Invest made significant trades on Friday, selling shares of RBLX, ROKU, PATH and buying shares of IBTA, PSNL, ABSI, and RXRX.
Via
Benzinga
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
March 03, 2025
From
Personalis, Inc.
Via
Business Wire
A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts
February 28, 2025
Via
Benzinga
Personalis Reports Fourth Quarter and Full Year 2024 Financial Results
February 27, 2025
From
Personalis, Inc.
Via
Business Wire
Earnings Scheduled For February 27, 2025
February 27, 2025
Via
Benzinga
Personalis Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
January 27, 2025
Via
Benzinga
Key Takeaways From Personalis Analyst Ratings
November 07, 2024
Via
Benzinga
Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference
February 18, 2025
From
Personalis, Inc.
Via
Business Wire
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday
February 14, 2025
Via
Benzinga
Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results
February 13, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 28, 2025
From
Personalis, Inc.
Via
Business Wire
What Analysts Are Saying About Personalis Stock
November 07, 2024
Via
Benzinga
New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer
January 13, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue
January 07, 2025
From
Personalis, Inc.
Via
Business Wire
Dow Surges Over 600 Points, Gold Jumps 1.5%
December 20, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses
December 20, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NASDAQ:PSNL),(NASDAQ:TEM),(NASDAQ:CKPT) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher
December 20, 2024
Via
Benzinga
Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday
December 20, 2024
Via
Benzinga
Stock Of The Day: Where Does The Merck Downtrend End?
December 19, 2024
Shares of Merck & Co (MRK) continue to trend lower. If they reach the $95.00 level, there is a good chance they find support and reverse.
Via
Benzinga
Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna
December 19, 2024
From
Personalis, Inc.
Via
Business Wire
Personalis and Tempus Expand Collaboration to Biopharma
December 16, 2024
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at Upcoming Investor Conferences
November 20, 2024
From
Personalis, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
November 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 07, 2024
Via
Benzinga
Personalis Reports Third Quarter 2024 Financial Results
November 06, 2024
From
Personalis, Inc.
Via
Business Wire
Personalis to Present at the Stifel 2024 Healthcare Conference
November 05, 2024
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce Third Quarter 2024 Financial Results
October 23, 2024
From
Personalis, Inc.
Via
Business Wire
ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test
September 16, 2024
From
Personalis, Inc.
Via
Business Wire
Biotech Stock Soars 60% in 2024: Cathie Wood’s Bold Investment
August 23, 2024
Tempus AI is a hot healthcare stock that investors should be aware of. It is using AI to pursue "precision medicine", especially in cancer research.
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Exposures
Artificial Intelligence
Personalis to Participate at Upcoming Investor Conferences
August 22, 2024
From
Personalis, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
